A double-blind trial of clonazepam in benign essential tremor.
Clonazepam has been reported to be of some value in the treatment of benign essential tremor in open trials. The efficacy of clonazepam was evaluated in a double-blind placebo-controlled study using up to 4 mg/day. By a variety of objective measures, clonazepam was not found to be an effective form of therapy.
D000328:Adult; D000368:Aged; D001570:Benzodiazepinones / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D002998:Clonazepam / Q000009:adverse effects / Q000627:therapeutic use*; D003221:Confusion / Q000139:chemically induced; D004311:Double-Blind Method; D007172:Erectile Dysfunction / Q000139:chemically induced; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D014202:Tremor / Q000188:drug therapy*
D001570:Benzodiazepinones; D002998:Clonazepam